Following the call from the UK’s chief medical officer to offer routine genome screening on the NHS, IPMI provider, Generali Global Health (GGH), has said genome testing is already routinely offered as part of their plans.

Marco Giacomelli, head of General Global Health, said “We added Genome Testing to our plan in early 2017, as we recognise this is critical in the effective treatment of cancer. This type of testing will become commonplace and enables a more precise healthcare pathway as the fight against cancer continues.”

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

GGH provides optional genome profiling for members diagnosed with cancer. This innovative swab-test identifies which course of treatment is most suitable based on analysis of the member’s genetic profile.

This means the member and their medical practitioner can have greater confidence in their chosen treatment plan.

Giacomelli added:“We agree with Dame Sally that this simple test can revolutionise the diagnosis and care of cancer sufferers in the future. We are one of the first insurers to offer this test to our members, but we believe it will become a widely used test globally.

“If the NHS can routinely provide this test it will position the UK as a leader in cancer diagnosis and treatment.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Giacomelli’s comments come after Ross Campbell life  / health chief underwriter, research & development at Gen Re, recently told Life Insurance International how genomics is becoming an essential issue for the life insurance industry as it would enable insurers to offer much more personalised policies.

With genetics and insurance, Campbell said fundamental issues are at stake.  However, he argues it is clear there are potentially significant benefits for consumers who allow access to data on their lifestyle, activity patterns, medical history and  genetic makeup.

Importantly, insurers would be able to offer much more personalised insurance policies that encourage engagement and improve outcomes for their customers, says Campbell.